Form 8-K - Current report:
SEC Accession No. 0001140361-25-000879
Filing Date
2025-01-13
Accepted
2025-01-13 08:00:29
Documents
45
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20041348_8k.htm   iXBRL 8-K 30293
2 EXHIBIT 99.1 ef20041348_ex99-1.htm EX-99.1 62488
6 ef20041348_ex99-1slide1.jpg GRAPHIC 109438
7 ef20041348_ex99-1slide2.jpg GRAPHIC 264688
8 ef20041348_ex99-1slide4.jpg GRAPHIC 159570
9 ef20041348_ex99-1slide5.jpg GRAPHIC 90347
10 ef20041348_ex99-1slide6.jpg GRAPHIC 163026
11 ef20041348_ex99-1slide7.jpg GRAPHIC 179461
12 ef20041348_ex99-1slide8.jpg GRAPHIC 111882
13 ef20041348_ex99-1slide9.jpg GRAPHIC 200801
14 ef20041348_ex99-1slide10.jpg GRAPHIC 174510
15 ef20041348_ex99-1slide11.jpg GRAPHIC 145093
16 ef20041348_ex99-1slide12.jpg GRAPHIC 138164
17 ef20041348_ex99-1slide13.jpg GRAPHIC 109704
18 ef20041348_ex99-1slide14.jpg GRAPHIC 114339
19 ef20041348_ex99-1slide15.jpg GRAPHIC 145227
20 ef20041348_ex99-1slide16.jpg GRAPHIC 154450
21 ef20041348_ex99-1slide17.jpg GRAPHIC 188502
22 ef20041348_ex99-1slide18.jpg GRAPHIC 139642
23 ef20041348_ex99-1slide19.jpg GRAPHIC 101146
24 ef20041348_ex99-1slide20.jpg GRAPHIC 147800
25 ef20041348_ex99-1slide21.jpg GRAPHIC 128225
26 ef20041348_ex99-1slide23.jpg GRAPHIC 148888
27 ef20041348_ex99-1slide24.jpg GRAPHIC 184885
28 ef20041348_ex99-1slide25.jpg GRAPHIC 193400
29 ef20041348_ex99-1slide26.jpg GRAPHIC 131398
30 ef20041348_ex99-1slide27.jpg GRAPHIC 127473
31 ef20041348_ex99-1slide28.jpg GRAPHIC 191035
32 ef20041348_ex99-1slide29.jpg GRAPHIC 179946
33 ef20041348_ex99-1slide31.jpg GRAPHIC 93429
34 page3.jpg GRAPHIC 202803
35 page22.jpg GRAPHIC 273983
36 page30.jpg GRAPHIC 197562
  Complete submission text file 0001140361-25-000879.txt   6985427

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA galt-20250113.xsd EX-101.SCH 4019
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20250113_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20250113_pre.xml EX-101.PRE 16069
48 EXTRACTED XBRL INSTANCE DOCUMENT ef20041348_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 25524868
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)